Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -260.5% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 14.2 | n/a |
Pr/Book | 1.5 |
Latest | F'cast | |
---|---|---|
Revenue | 35.1% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1.52 | 5.71 | 6.65p | 8.7 | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2.21 | 6.18 | 7.15p | 6.4 | 0.8 | +8% | n/a | 0.0% |
31-Dec-22 | 0.46 | 2.44 | 2.93p | 4.5 | n/a | -59% | n/a | 0.0% |
31-Dec-23 | 0.64 | (2.04) | (2.24)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | 0.87 | (1.87) | (1.84)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Final Results | 30-Jun-2025 | 07:00 | RNS |
Change of Broker | 30-Jun-2025 | 07:00 | RNS |
Placing and Issue of Warrants | 23-May-2025 | 07:00 | RNS |
£5.7m float for weight-fighting OptiBiotix after... | 04-Aug-2014 | Express & Star |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 12.00p |
Change Today | 0.75p |
% Change | 6.67 % |
52 Week High | 33.00 |
52 Week Low | 10.25 |
Volume | 419,813 |
Shares Issued | 103.30m |
Market Cap | £12.40m |
Beta | 0.02 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:25 | 1 @ 12.47p |
16:24 | 1 @ 12.47p |
16:24 | 1 @ 12.47p |
16:24 | 1 @ 12.47p |
16:23 | 1 @ 12.47p |
CEO | Stephen O'Hara |
Finance Director | David Blain |
You are here: research